未登录

M

Marc L. Fleming

university of texas austin

H指数:19

被引数:964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Substance use disorder among people with intellectual and developmental disabilities: a narrative review

智力与发育障碍患者中的物质使用障碍：一项叙事综述

American Journal of Drug and Alcohol Abuse

IF2.6

2026-02-010

OA

Is there a disparity in medications for opioid use disorder based on race/ ethnicity and gender? A systematic review and meta-analysis

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2024-03-0116

PRE

Positive Changes in Safety Perception Among Blacks with HIV and Comorbidities: Assessment of Social Determinants of Health During COVID-19

患有HIV和合并症的黑人的安全认知的积极变化: 新型冠状病毒肺炎期间健康的社会决定因素的评估

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES

IF2.4

2023-05-220

OAAI

A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes

IF3.8

2023-02-279

OAAI

Impact of geographic access to primary care providers on pediatric behavioral health screening

PREVENTIVE MEDICINE

IF3.2

2021-12-017

PRE

Using the Theory of Planned Behavior to Evaluate Factors That Influence PharmD Students' Intention to Attend Lectures

运用计划行为理论评估影响PharmD学生听课意向的因素

AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION

IF3.5

2020-05-0114

OAAI

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2019-10-019

OAAI

Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2019-08-0144

OAAI

Global research initiatives to understand the prescription drug misuse epidemic and ways to monitor and intervene

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2019-08-011

PREAI

The association between geographic access to providers and the treatment quality of pediatric depression

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2019-06-0113

PREAI

UNDERSTANDING TEXAS COMMUNITY PHARMACISTS' ATTITUDES TOWARD MANDATED PDMP USE AND SEVEN DAY PRESCRIBING LIMITS ON OPIOID PRESCRIPTIONS FOR ACUTE NON-CANCER PAIN

VALUE IN HEALTH

IF6

2019-05-010

OAAI

IMPACT OF GEOGRAPHIC ACCESS TO PROVIDERS ON TREATMENT ENGAGEMENT AND COMPLETION IN PEDIATRIC DEPRESSION POPULATION IN SOUTHEAST TEXAS

VALUE IN HEALTH

IF6

2019-05-010

OAAI

CHANGES IN ANALGESIC PRESCRIBING AMONG TEXAS ADVANCED PRACTICE PROVIDERS AFTER RESCHEDULING OF HYDROCODONE COMBINATION PRODUCTS

VALUE IN HEALTH

IF6

2019-05-010

OAAI

GEOGRAPHIC ACCESS TO PRIMARY CARE PROVIDER AND BEHAVIORAL DISORDER SCREENING: VARIATIONS ACROSS RACE/ETHNICITY

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

IF9.5

2018-10-010

PREAI

MID-LEVEL PRACTITIONERS INTENTION TO PRESCRIBE ACETAMINOPHEN WITH CODEINE

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2018-06-010

PREAI

Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2017-05-0116

PREAI

FEASIBILITY OF A PHONE-BASED MOTIVATIONAL INTERVIEWING INTERVENTION TO IMPROVE MEDICATION ADHERENCE BY PHARMACY STUDENTS ON ADVANCED PHARMACY PRACTICE EXPERIENCE ROTATION IN A MEDICARE ADVANTAGE WITH PRESCRIPTION DRUG PLAN

VALUE IN HEALTH

IF6

2016-05-010

OAAI

RESCHEDULING HYDROCODONE COMBINATION PRODUCTS: ASSESSING THE IMPACT ON OPIOID UTILIZATION

VALUE IN HEALTH

IF6

2016-05-012

OAAI

IMPACT OF LONG TERM OPIOID USE ON ORAL ANTIHYPERGLYCEMIC MEDICATION ADHERENCE AMONG INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS: A RETROSPECTIVE DATABASE ANALYSIS

VALUE IN HEALTH

IF6

2016-05-010

OAAI

MEDICATION UTILIZATION PATTERN FOR PAIN MANAGEMENT AMONG INDIVIDUALS WITH TYPE 2 DIABETES

VALUE IN HEALTH

IF6

2015-05-010

OAAI